Privately-held Swiss biotech Memo Therapeutics has announced results from its Phase II trial evaluating potravitug, a highly-potent human BK polyomavirus (BKPyV)-neutralizing monoclonal antibody, for ...

The European Medicines’ (EMA) human medicines committee (CHMP) has recommended seven novel medicines for approval at its July ...

TCG Labs Soleil has secured another $400 million to expand its global R&D footprint and help build out its growing portfolio ...

As if there had not been enough negative news regarding Elevidys (delandistrogene moxeparvovec) this month, there was more ...

French diabetes and obesity specialist Adocia was trading 45% higher late Friday following its partner Tonghua Dongbao’s ...

It has been a stellar week for Abivax, a French biotech developing therapeutics that harness the body’s natural regulatory ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...

The Trump administration has asked the US Supreme Court to allow the National Institutes of Health (NIH) to resume canceling ...

French drugmaker Ipsen announced that the European Commission (EC) has approved Cabometyx (cabozantinib) for adult patients ...

In an import contrast to events in the USA, UK pharma major GSK late Thursday announced the approval of Blenrep (belantamab ...

Swiss pharma major Novartis (NOVN: VX) has entered into an exclusive option and license deal with Matchpoint Therapeutics to ...